Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study

[1]  B. Spiessl,et al.  Head and Neck Tumours , 2010 .

[2]  E. Baker,et al.  Plasminogen activator system in oral squamous cell carcinoma. , 2007, The British journal of oral & maxillofacial surgery.

[3]  M. Stack,et al.  Urinary-type plasminogen activator (uPA) and its receptor (uPAR) in squamous cell carcinoma of the oral cavity. , 2007, The Biochemical journal.

[4]  Hongyu Wei,et al.  Expression of urokinase-type plasminogen activator receptor is correlated with metastases of lingual squamous cell carcinoma. , 2006, The British journal of oral & maxillofacial surgery.

[5]  B. Nielsen,et al.  Expression of plasminogen activator inhibitor‐1, urokinase receptor and laminin γ‐2 chain is an early coordinated event in incipient oral squamous cell carcinoma , 2006, International journal of cancer.

[6]  M. Stack,et al.  Functional Relevance of Urinary-type Plasminogen Activator Receptor-α3β1 Integrin Association in Proteinase Regulatory Pathways* , 2006, Journal of Biological Chemistry.

[7]  R. Montironi,et al.  Immunohistochemical evaluation of urokinase plasminogen activator receptor in noninvasive and early invasive urothelial papillary neoplasia. , 2004, Analytical and quantitative cytology and histology.

[8]  H. Schliephake,et al.  Prognostic relevance of molecular markers of oral cancer--a review. , 2003, International journal of oral and maxillofacial surgery.

[9]  M. Stack,et al.  Loss of adhesion‐regulated proteinase production is correlated with invasive activity in oral squamous cell carcinoma , 2002, Cancer.

[10]  M. Stack,et al.  Urinary-type Plasminogen Activator (uPA) Expression and uPA Receptor Localization Are Regulated by α3β1Integrin in Oral Keratinocytes* , 2000, The Journal of Biological Chemistry.

[11]  F. Hoppe,et al.  Urokinase receptor up‐regulation in head and neck squamous cell carcinoma , 2000, Head & neck.

[12]  H. Welkoborsky,et al.  Tumorbiologische Prognoseparameter beim T 1 N 0 M 0 -Plattenepithelkarzinom der Mundhöhle* , 1999 .

[13]  J. Gluckman,et al.  [Tumor biologic prognostic parameters in T1N0M0 squamous cell carcinoma of the oral cavity]. , 1999, Laryngo- rhino- otologie.

[14]  S. Rabbani.  Metalloproteases and urokinase in angiogenesis and tumor progression. , 1998, In vivo.

[15]  K. Nakagawa,et al.  Immunohistochemical localization of a urokinase-type plasminogen activator system in squamous cell carcinoma of the oral cavity: association with mode of invasion and lymph node metastasis. , 1998, Oral oncology.

[16]  F. Blasi.  uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways? , 1997, Immunology today.

[17]  C. V. D. van de Velde,et al.  Prognostic value of the plasminogen activation system in patients with gastric carcinoma , 1996, Cancer.

[18]  N. Brünner,et al.  Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  N. Brünner,et al.  The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion , 1995 .

[20]  N. Brünner,et al.  Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue. , 1994, Cancer research.

[21]  H. Verspaget,et al.  Urokinase receptor and colorectal cancer survival , 1994, The Lancet.

[22]  G. Nicolson,et al.  Regulation of urokinase‐type plasminogen activator expression in squamous‐cell carcinoma of the oral cavity , 1993, International journal of cancer.

[23]  B. Gustavsson,et al.  Cell membrane receptors for urokinase plasminogen activator are increased in malignant ovarian tumours. , 1991, European journal of cancer.

[24]  M. Ploug,et al.  Cell‐induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2‐terminal domain of the urokinase receptor , 1991, FEBS letters.